Product Information
ZOLMITRIPTAN 2.5 MG ODT is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $2.2670 per EA under NDC 68462049976. Its NADAC has been published 636 times since Nov 28, 2013.
Strength
2.5 mg/1
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462049976
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA202560On Market Since
5/14/2013
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 2.5 MG ODT has been published 636 times since Nov 28, 2013, and over the history we have for it it has declined 70.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.2670 per EA |
|---|---|
| All-time high | $8.5677 (Aug 12, 2015) |
| All-time low | $2.0689 (Nov 20, 2024) |
| 52-week high | $2.4682 |
| 52-week low | $2.2416 |
| Median price | $4.1220 |
| Average price | $4.7862 |
| Largest weekly change | +88.4% (Jul 20, 2022) |
| Weeks tracked | 636 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the zolmitriptan market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 2.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG ODT, manufactured by Glenmark Pharmaceuticals Inc., USA, is $2.2670 per EA (NDC 68462049976), effective Jun 24, 2026.
How has the price of ZOLMITRIPTAN 2.5 MG ODT changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has declined 70.8%. It has been tracked across 636 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG ODT?
Since Nov 28, 2013, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has ranged from a low of $2.0689 (Nov 20, 2024) to a high of $8.5677 (Aug 12, 2015), with a median of $4.1220 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG ODT?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ZOLMITRIPTAN 2.5 MG ODT, so no direct lower-cost alternative is listed.
Who manufactures ZOLMITRIPTAN 2.5 MG ODT?
ZOLMITRIPTAN 2.5 MG ODT (NDC 68462049976) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.
Related Drugs
Same classification